Related Experiment Video
Updated: Jun 12, 2026
04:23
A Treatment Package without Escape Extinction to Address Food Selectivity
Published on: August 21, 2015
Clinical practice: drug desensitization in children
1Department of Pediatric Allergology, Diaconessenhuis Voorburg, RdGG, Fonteynenburghlaan 5, Voorburg, the Netherlands. grooth@rdgg.nl
European Journal of Pediatrics
|June 24, 2010
Summary
Drug desensitization is a critical procedure for children with IgE-mediated allergies when no alternative medications exist. This review examines desensitization protocols for antibiotics, antineoplastics, and vaccines in pediatric patients.
Area of Science:
- Pediatric Allergy and Immunology
- Clinical Pharmacology
Background:
- Immediate hypersensitivity reactions to medications pose significant risks in children, potentially limiting essential treatments.
- Accurate data on the incidence and prevalence of these reactions in pediatric populations are scarce.
- Drug desensitization offers a viable option for continuing necessary therapies when no safe alternatives are available.
Purpose of the Study:
- To review existing literature on drug desensitization procedures for antibiotics, antineoplastic agents, and vaccines in children.
- To identify key considerations and challenges in pediatric drug desensitization.
- To summarize current evidence regarding the efficacy and safety of desensitization in pediatric patients.
Main Methods:
- Systematic literature review of studies involving drug desensitization in children.
- Analysis of desensitization protocols for various drug classes, including antibiotics, antineoplastics, and vaccines.
- Evaluation of data on dosage adjustments and premedication strategies in pediatric desensitization.
Main Results:
- Pediatric desensitization schemes generally mirror adult protocols, differing primarily in the final dosage.
- The review encompasses desensitization procedures for a range of critical medications used in pediatric care.
- Inconclusive findings were reported regarding the efficacy of antihistamines and glucocorticoids as premedication for preventing allergic reactions during desensitization.
Conclusions:
- Drug desensitization is a valuable, albeit specialized, procedure for managing immediate allergic reactions in children.
- Careful patient selection and performance by trained specialists in a controlled setting are paramount.
- Further research is needed to clarify the role and optimal use of premedication in pediatric drug desensitization.
Related Concept Videos
01:20Desensitization and Tachyphylaxis
Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
Several...
Several...
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
01:29Drug Dosing: Infants and Children
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
01:21Factors Affecting Drug Response: Overview
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...